The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

Taipei City Hospital, Taipei, Taiwan

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01360567

Enrollment

102

Registered

2011-05-25

Start date

2011-05-31

Completion date

2012-12-31

Last updated

2013-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia, Type 2 Diabetes

Keywords

green tea, EGCG, type 2 diabetes, hyperlipidemia

Brief summary

The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.

Detailed description

Percent change Homa insulin resistance, cholesterol and triglycerol.

Interventions

DIETARY_SUPPLEMENTGreen tea extract

500 mg . one capsule of green tea extract, 3 times per day

DIETARY_SUPPLEMENTPlacebo

500 mg . one capsule of placebo, 3 times per day

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Age 20--69 years old * Type 2 diabetes for \> one year * TG \>= 150 mg/dl or LDL \>= 100 mg/dl

Exclusion criteria

* GPT \> 80 mg/dl * Creatinine \> 1.8 mg/dl * Pregnancy * AMI * Stroke * Operational or any not suitable patients diagnosis physician in charge

Design outcomes

Primary

Measure	Time frame
Percent change of HOMA insulin resistance and TG	16 weeks

Secondary

Measure	Time frame
Percent change of HbA1C and Cholesterol	16 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026